❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Immunology ❭ Cell Signaling and Immune Regulation [Taskén] ❭
Page visits: 1
Scroll to top

Home Dept. of Cancer Immunology Cell Signaling and Immune Regulation [Taskén]

  • Group members
  • Research
  • Group Achievements
  • Publications
  • Gallery
  • News and Vacancies
  • Sigrid Skånland's project group

Recent publications

Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R (2025)
Cancer treatment paradigms in the precision medicine era
Nat Med (in press)
DOI 10.1038/s41591-025-03711-w, PubMed 40394190

Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia
Clin Cancer Res, 31 (10), 1943-1955
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Taskén K, Mahon P (2025)
Accelerating precision oncology by converging pragmatic trials and real-world evidence
Nat Rev Drug Discov (in press)
DOI 10.1038/d41573-025-00047-5, PubMed 40082591

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)